Atlas Trials

Christine Ryan

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Christine Ryan

RecordFirmDate
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma (NCT06854003)Christine Ryan2025-04-22
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation (NCT06043674)Christine Ryan2024-01-22

Track Christine Ryan automatically

Every clearance here is in the API, with alerts when new ones post.